Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 159 clinical trials
Data Collection of Standard Care and Evaluation of NHLBI Patients and Donors

Eligibility People age 2 and older who have or are suspected to have a medical condition for which they have been referred to NIH s National Heart, Lung, and Blood Institute, as well as stem cell donors Design Participants may be screened with a review of the following: Medical records …

urine test
x-rays
apheresis
  • 0 views
  • 19 Feb, 2024
Pharmacokinetics Pharmacodynamics and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

The study investigators are interested in learning more about how drugs, that are given to children by their health care provider, act in the bodies of children and young adults in hopes to find the most safe and effective dose for children. The primary objective of this study is to …

acute respiratory syndrome (sars)
SARS
  • 0 views
  • 19 Feb, 2024
COVID-19 and Cancer Patients

Routinely collected data will be used to assess the morbidity and mortality of cancer patients following a positive COVID-19 infection.

covid-19
cancer
acute respiratory syndrome (sars)
SARS
  • 0 views
  • 19 Feb, 2024
Genetics of COVID-19 Susceptibility and Manifestations

Background The current SARS-CoV-2 pandemic presents a serious challenge to public health. Some people who are infected with SARS-CoV-2 have mild symptoms or none at all. But others develop severe symptoms, like pneumonia or organ failure. Researchers think that people s genes might play a role in how sick they …

pneumonia
acute respiratory syndrome (sars)
organ failure
SARS
covid-19
  • 0 views
  • 19 Feb, 2024
A Study to Identify Errors in Inhaler Technique in Adults

This study will observe the inhaler technique of people using 13 different inhaler types; record any technique errors being made against checklists developed for each inhaler device based on their manufacturer's guidelines, and reeducate any observed inhaler technique errors as required.

  • 0 views
  • 19 Feb, 2024
RASopathy Biorepository

The RASopathies are a group of developmental disorders caused by genetic changes in the genes that compose the Ras/mitogen activated protein kinase (MAPK) pathway. New RASopathies are being diagnosed frequently. This pathway is essential in the regulation of the cell cycle and the determination of cell function. Thus, appropriate function …

genetic testing
cancer
heart defects
  • 0 views
  • 19 Feb, 2024
The Real World Study of Neoadjuvant Immunotherapy in Early Stage NSCLC in China

Several published clinical trials have shown the superiority of immunotherapy in neoadjuvant setting. Here we conducted this real world study to see whether neoadjuvant immunotherapy would bring MPR and survival benefits in NSCLC, for example, single agent immunotherapy or immunotherapy combination with chemotherapy. Furthermore biomarker analysis would be also performed …

measurable disease
cancer
EGFR
alk gene translocation
small cell lung cancer
  • 0 views
  • 19 Feb, 2024
Classification of Benign and Malignant Lung Nodules Based on CT Raw Data

The employ of medical images combined with deep neural networks to assist in clinical diagnosis, therapeutic effect, and prognosis prediction is nowadays a hotspot. However, all the existing methods are designed based on the reconstructed medical images rather than the lossless raw data. Considering that medical images are intended for …

cancer
  • 0 views
  • 19 Feb, 2024
Lung Ultrasound in COVID-19 Patients

To assess the prognostic performance of an early global LUS score with respect to the mortality in ICU and duration of ventilation.

covid-19
PCR test
lung ultrasound
  • 0 views
  • 19 Feb, 2024
Immunotherapy in Lung Cancer: Treatment After IO Cessation.

Immunotherapy is now a standard of care for first-line and eventually salvage therapy in patients with stage IV NSCLC and as adjuvant after RT-CT for stage III NSCLC. The aim of the study is determining the therapeutic landscape and the reason for immunotherapy cessation.

stage iv non-small cell lung cancer
adjuvant
cancer
carcinoma in situ
salvage therapy
  • 0 views
  • 19 Feb, 2024